London, UK. January 5, 2015

md:ceuticals launches Chinese-language website

Innovation and inclusion are vital to an effective partnership with customers, and understanding this, md:ceuticals has launched a Chinese-language website for the Chinese-speaking community. Our efforts will enhance communications and will improve our ability to reach prospective patients, satisfying their specific needs.

Thanks to its large population and rapid economic development, China has undergone a significant transformation and expansion in its beauty and personal care industry over the past decade. The country’s cosmetics market is worth $26 billion a year, making it the third-biggest in the world.


Kuwait city, Kuwait. November 27, 2014

Update on the newest peel protocols for Kuwait customers:

On the 27th of November 2014, our team of professional product advisors conducted a one-day seminar for a strictly limited number of attendees in Kuwait, giving fellow professionals the opportunity to experience md:ceuticals methods first hand, and learn the specific md:peel treatment protocols to repair and rejuvenate skin.

The seminar reviewed the indications, benefits, and treatment protocols of each of the md:peel professional treatment and daily care regimens which are employed to give the therapists the tools necessary to diagnose different skin conditions. It also demonstrated how to select the most appropriate services for their patients’ distinct skin concerns.


London, UK - October 5, 2014

md:complex Hair-Revit makes breakthrough in battle against hair loss:

Alopecia is a hair loss disease that affects men and women, and is generally caused by various factors such as serious disease, medication, trauma, stress, hormonal changes, environmental and genetic factors. Although not damaging to physical health, alopecia can have severe effects on quality of life and emotional health through its impact on confidence and self-esteem.

Androgenetic alopecia (AGA) is the most common type of progressive hair loss and is caused by a combination of genetic and hormonal factors. It affects about 50% of men over the age of 50, and about 50% of women over the age of 65. The main hormone responsible for androgenetic alopecia in genetically susceptible individuals is DHT (Dihydrotestosterone). DHT reduces the anagen phase of the follicle cycles, shortening the hair life cycle, and gradually miniaturising the follicles.